Intranasal oxytocin treatment restored impaired maternal licking behavior in Shank3-mutant dogs — a novel large-animal model of autism — suggesting a potential therapeutic strategy for social behavior deficits in SHANK3-associated autism.
Maternal behavior rescued by intranasal oxytocinBoth acute and chronic oxytocin treatment significantly improved licking behavior deficits in Shank3 mutant dams, linking genetic autism risk to treatable oxytocin system dysfunction
What the researchers found
Shank3 mutant mother dogs exhibited significantly fewer and shorter licking bouts and reduced nursing frequency compared to wild-type dams. Blood oxytocin concentrations were significantly decreased in mutant dams. A two-week vehicle-controlled intranasal oxytocin treatment, starting on postpartum day 8, significantly rescued the licking behavior deficits both acutely and chronically. This demonstrates that the maternal behavior impairments in these autism-model dogs are at least partly driven by oxytocin system dysfunction.
Why it matters
Most autism research uses mice, but dogs are far more socially complex and may better model human social behavior deficits. This study validates Shank3-mutant dogs as a new large-animal autism model and provides compelling evidence that oxytocin can rescue specific social behavior deficits caused by this genetic mutation. The finding that both acute and chronic oxytocin treatment worked is particularly encouraging for therapeutic development, as it suggests sustained benefit rather than just a temporary effect.
How the study worked
Researchers generated Shank3 mutant domestic dogs using CRISPR/Cas9 gene editing. Maternal behaviors (licking frequency, licking duration, nursing frequency) were quantified in mutant and wild-type dams with their puppies. Blood oxytocin levels were measured. A vehicle-controlled experiment tested two weeks of intranasal oxytocin treatment beginning on postpartum day 8, with both acute and chronic behavioral assessments.
What this study cannot tell us
The abstract does not specify the number of dogs in each group, making it difficult to assess statistical power. Dogs, while more socially complex than mice, are still not humans, and maternal licking is only one facet of social behavior. The two-week treatment window is short, and long-term effects are unknown. The study focused on a single gene (SHANK3), which accounts for only a subset of autism cases. Intranasal oxytocin delivery to the brain is not fully understood even in humans.
How to read the evidence
This is a preclinical animal study using a novel gene-edited dog model with a vehicle-controlled design. The methodology is rigorous (CRISPR gene editing, controlled treatment) and the dog model is more translationally relevant than rodents. However, sample sizes are not specified in the abstract, and the findings have not been validated in humans.
When this study was published
Published in 2025, this is a very recent study representing the cutting edge of large-animal autism models and peptide-based neuropsychiatric therapy research.
The bigger picture
Oxytocin has been studied for over a decade as a potential autism therapy, with mixed results in human clinical trials. This study brings two important advances: a more translationally relevant animal model (dogs instead of mice) and a clear genetic link (SHANK3 mutation) connecting low oxytocin to specific social behavior deficits. Understanding which genetic subtypes of autism respond to oxytocin could be key to why human trials have shown inconsistent results — some patients may benefit while others don't, depending on their underlying genetics.
Questions still open
- Would oxytocin treatment also improve other social behaviors (not just maternal) in Shank3 mutant dogs, such as interaction with other dogs or humans?
- Could these findings help identify which human autism patients (e.g., those with SHANK3 mutations) are most likely to respond to oxytocin therapy?
Common questions
Why use dogs instead of mice for autism research?
What is SHANK3 and why is it important for autism?
Read the original research
Oxytocin improves maternal licking behavior deficits in autism-associated Shank3 mutant dogs.
Translational psychiatry, 15(1), 76
Citation
Lyu, Wen; Li, Yuan; Yao, Aiyu; Tan, Qing-Quan; Zhang, Rong; Zhao, Jian-Ping; Guo, Kun; Jiang, Yong-Hui; Tian, Rui; Zhang, Yong Q. (2025). Oxytocin improves maternal licking behavior deficits in autism-associated Shank3 mutant dogs.. Translational psychiatry, 15(1), 76. https://doi.org/10.1038/s41398-025-03296-5